Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Apyx Medical Corp APYX

Apyx Medical Corporation is an advanced energy technology company. The Company's segments include Advanced Energy and OEM. The Advanced Energy segment's product portfolio consists of its Helium Plasma Technology that is marketed and sold as Renuvion in the cosmetic surgery market and J-Plasma in the hospital surgical market. It is focused on the cosmetic surgery market where Renuvion offers... see more

Recent & Breaking News (NDAQ:APYX)

 Apyx Medical Corporation Announces Appointment of Wendy Levine to the Company's Board of Directors

Business Wire August 30, 2021

Apyx Medical Corporation Reports Second Quarter 2021 Financial Results and Updates Full Year 2021 Outlook

Business Wire August 12, 2021

Apyx Medical Corporation to Release Second Quarter of Fiscal Year 2021 Financial Results on August 12, 2021

Business Wire July 12, 2021

Digital Health Could Help Fix the Broken U.S. Healthcare Market

Press Releases June 24, 2021

Some of the Top Ways to Invest in a Potential $379 Billion Digital Health Market

Press Releases June 22, 2021

Digital Health Monitoring Creating a $245 Billion Investment Opportunity

Press Releases June 16, 2021

Apyx Medical Corporation to Participate in the JMP Securities Life Sciences Conference

Business Wire June 3, 2021

Apyx Medical Corporation Announces FDA 510(k) Submission for the Use of Renuvion® in Dermal Resurfacing Procedures

Business Wire June 1, 2021

Apyx Medical Corporation Reports First Quarter 2021 Financial Results and Updates Full Year 2021 Outlook

Business Wire May 12, 2021

Apyx Medical Corporation to Release First Quarter of Fiscal Year 2021 Financial Results on May 12, 2021

Business Wire April 12, 2021

Apyx Medical Corporation Reports Fourth Quarter and Full Year 2020 Financial Results; Introduces Full Year 2021 Financial Outlook

Business Wire March 31, 2021

Apyx Medical Corporation to Release Fourth Quarter and Fiscal Year 2020 Financial Results on March 31, 2021

Business Wire February 1, 2021

Apyx Medical Corporation Reports Preliminary Full Year and Fourth Quarter 2020 Revenue Results

Business Wire January 13, 2021

Apyx Medical Corporation to Participate in the ICR Conference 2021

Business Wire January 5, 2021

Apyx Medical Corporation Announces Approval from FDA to Begin Phase II of U.S. IDE Study

Business Wire November 23, 2020

Apyx Medical Corporation Reports Third Quarter 2020 Financial Results

Business Wire November 9, 2020

Apyx Medical Corporation Announces Updates on U.S. IDE Clinical Studies

Business Wire November 9, 2020

Apyx Medical Corporation to Participate in Upcoming Investor Conferences in November and December

Business Wire November 3, 2020

Apyx Medical Corporation Announces Two Peer-Reviewed Clinical Publications Evaluating Renuvion's Helium Plasma Technology

Business Wire October 20, 2020

Apyx Medical Corporation to Release Third Quarter of Fiscal Year 2020 Financial Results on November 9, 2020

Business Wire October 1, 2020